Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Proteome Research

• Publication date

  2017-01-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1021/acs.jproteome.6b00559PMID 27769114
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules

  2016cited by this paper
• Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer

  2015cited by this paper
• Randomized Study on Early Detection of Lung Cancer with MSCT in Germany: Results of the First 3 Years of Follow-up After Randomization

  2015cited by this paper
• PGTools: A Software Suite for Proteogenomic Data Analysis and Visualization.

  2015cited by this paper
• Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.

  2015cited by this paper
• UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Cancer treatment and survivorship statistics, 2014

  2014cited by this paper
• Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force

  2014cited by this paper
• Quantitative assessment of the robustness of next-generation sequencing of antibody variable gene repertoires from immunized mice

  2014cited by this paper
• An integrated top‐down and bottom‐up proteomic approach to characterize the antigen‐binding fragment of antibodies

  2014cited by this paper
• Peptides from the Variable Region of Specific Antibodies Are Shared among Lung Cancer Patients

  2014cited by this paper
• Detection of circulating antibodies to linear peptide antigens derived from ANXA1 and DDX53 in lung cancer

  2014cited by this paper
• Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer

  2014cited by this paper
• A novel autoantibody test for the detection of pre-neoplastic lung lesions

  2014cited by this paper
• Onco-proteogenomics: cancer proteomics joins forces with genomics

  2014cited by this paper
• udit of the autoantibody test , EarlyCDT ®-Lung , in 1600 patients : n evaluation of its performance in routine clinical practice

  2014cited by this paper
• Development of a Multiplex Autoantibody Test for Detection of Lung Cancer

  2014cited by this paper
• Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial

  2013cited by this paper
• Screening for Lung Cancer With Low-Dose Computed Tomography: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation

  2013cited by this paper
• The pivotal role of pathology in the management of lung cancer.

  2013cited by this paper
• A Blood-Based Proteomic Classifier for the Molecular Characterization of Pulmonary Nodules

  2013cited by this paper
• Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

  2013cited by this paper
• Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.

  2013cited by this paper
• Early Detection of NSCLC with scFv Selected against IgM Autoantibody

  2013cited by this paper
• Results of the two incidence screenings in the National Lung Screening Trial.

  2013cited by this paper
• Biomarkers to help guide management of patients with pulmonary nodules.

  2013cited by this paper
• Added Value of a Serum Proteomic Signature in the Diagnostic Evaluation of Lung Nodules

  2012cited by this paper
• Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial

  2012cited by this paper
• Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

  2012cited by this paper
• Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Mass spectrometric detection of antigen-specific immunoglobulin peptides in paraneoplastic patient sera.

  2012cited by this paper
• Benefits and harms of CT screening for lung cancer: a systematic review.

  2012cited by this paper
• A Multiplexed Serum Biomarker Immunoassay Panel Discriminates Clinical Lung Cancer Patients from High-Risk Individuals Found to be Cancer-Free by CT Screening

  2012cited by this paper
• EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays

  2012cited by this paper
• CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT

  2012cited by this paper
• Rep‐Seq: uncovering the immunological repertoire through next‐generation sequencing

  2012cited by this paper
• Reduced lung-cancer mortality with low-dose computed tomographic screening.

  2011cited by this paper
• EarlyCDT-Lung: An Immunobiomarker Test as an Aid to Early Detection of Lung Cancer

  2011cited by this paper
• Small cell lung cancer.

  2011cited by this paper
• Pentraxin-3 Is a Novel Biomarker of Lung Carcinoma

  2011cited by this paper
• Immunogenicity of autoantigens

  2011cited by this paper
• Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

  2011cited by this paper
• Structural analysis of intact monoclonal antibodies by electron transfer dissociation mass spectrometry.

  2011cited by this paper
• UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer

  2011cited by this paper
• Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer

  2010cited by this paper
• Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers

  2010cited by this paper
• Immune Responses Are Characterized by Specific Shared Immunoglobulin Peptides That Can Be Detected by Proteomic Techniques*

  2010cited by this paper
• Development of a Multiplexed Tumor-Associated Autoantibody-Based Blood Test for the Detection of Non–Small Cell Lung Cancer

  2010cited by this paper
• Development of Autoantibody Signatures as Novel Diagnostic Biomarkers of Non–Small Cell Lung Cancer

  2010cited by this paper
• Clinical validation of an autoantibody test for lung cancer

  2010cited by this paper
• Technical validation of an autoantibody test for lung cancer

  2010cited by this paper
• Structure and function of immunoglobulins.

  2010cited by this paper
• Dickkopf-1 autoantibody is a novel serological biomarker for non-small cell lung cancer

  2010cited by this paper
• Identification of lung cancer with high sensitivity and specificity by blood testing

  2010cited by this paper
• High-Throughput Sequencing of the Zebrafish Antibody Repertoire

  2009cited by this paper
• Management of lung nodules detected by volume CT scanning.

  2009cited by this paper
• Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.

  2009cited by this paper
• A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial.

  2009cited by this paper
• The Danish Randomized Lung Cancer CT Screening Trial—Overall Design and Results of the Prevalence Round

  2009cited by this paper
• Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer.

  2009cited by this paper
• Serum autoantibodies as biomarkers for early cancer detection

  2009cited by this paper
• Autoantibody profiling for cancer detection.

  2009cited by this paper
• Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial.

  2008cited by this paper
• Cancer Immunology

  2008cited by this paper
• Who is at high risk for lung cancer? Population-level and individual-level perspectives.

  2008cited by this paper
• Toward an early diagnosis of lung cancer: An autoantibody signature for squamous cell lung carcinoma

  2008cited by this paper
• Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera.

  2008cited by this paper
• VH gene usage and CDR3 analysis of B cell receptor in the peripheral blood of patients with PBC

  2008cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

  2007cited by this paper
• Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).

  2007cited by this paper
• Autoantibodies in lung cancer: possibilities for early detection and subsequent cure

  2007cited by this paper
• Risk‐based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch‐Belgian randomised lung cancer multi‐slice CT screening trial (NELSON)

  2007cited by this paper
• Panel of serum biomarkers for the diagnosis of lung cancer.

  2007cited by this paper
• Models for antigen receptor gene rearrangement: CDR3 length

  2007cited by this paper
• Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.

  2007cited by this paper
• Extensive restrictions in the VH sequence usage of the human antibody response against the Rhesus D antigen.

  2007cited by this paper
• Diagnostic Accuracy of MALDI Mass Spectrometric Analysis of Unfractionated Serum in Lung Cancer

  2007cited by this paper
• Cancer Immunomics Using Autoantibody Signatures for Biomarker Discovery*

  2007cited by this paper
• Identification of 14-3-3θ as an antigen that induces a humoral response in lung cancer

  2007cited by this paper
• Survival of Patients with Clinical Stage I Lung Cancer Diagnosed by Computed Tomography Screening for Lung Cancer

  2007cited by this paper
• Lung cancer preneoplasia.

  2006cited by this paper
• Nodule management protocol of the NELSON randomised lung cancer screening trial.

  2006cited by this paper
• Profiling Tumor-Associated Antibodies for Early Detection of Non-small Cell Lung Cancer

  2006cited by this paper
• [Guideline on 'non-small cell lung carcinoma; staging and treatment'].

  2005cited by this paper
• The sentinel within: exploiting the immune system for cancer biomarkers.

  2005cited by this paper
• Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.

  2005cited by this paper
• Immune response as a biomarker for cancer detection and a lot more.

  2005cited by this paper
• Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer.

  2005cited by this paper
• Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis

  2005cited by this paper
• Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer.

  2004cited by this paper
• The immunobiology of cancer immunosurveillance and immunoediting.

  2004cited by this paper
• Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis

  2003cited by this paper
• Harnessing immunity for cancer marker discovery

  2003cited by this paper
• Molecular biology of lung cancer: clinical implications.

  2002cited by this paper
• The Human Plasma Proteome

  2002cited by this paper
• Somatic Hypermutation Shapes the Antibody Repertoire of Memory B Cells in Humans

  2001cited by this paper
• Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities.

  2000cited by this paper
• Somatic insertions and deletions shape the human antibody repertoire.

  1999cited by this paper

• Biomarkers for the diagnosis of indeterminate pulmonary nodules: are we there yet?

  2025cites this paper
• Development of high-titer class-switched antibody responses to phosphorylated amino acids is prevalent in pancreatic ductal adenocarcinoma

  2025cites this paper
• Association between high-density lipoprotein cholesterol and 7-autoantibodies: a study on physical examination data from 2018 to 2023

  2025cites this paper
• Serum ZFPL1 as a clinical biomarker for diagnosis, progression tracking, and treatment response in lung cancer.

  2025cites this paper
• Dual-responsive electrochemical immunosensor for CYFRA21-1 detection based on Au/Co Co-loaded 3D ordered macroporous carbon interconnected framework.

  2024cites this paper
• Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer

  2024cites this paper
• Clinical application of serum seven tumour-associated autoantibodies in patients with pulmonary nodules

  2024cites this paper
• Precise diagnosis and prognosis assessment of malignant lung nodules: a narrative review

  2024cites this paper
• Screening of Cancer-Specific Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma Based on a Proteome Microarray

  2024cites this paper
• Clinical Value of Seven Autoantibodies Against Tumor-Associated Antigens and Tumor Markers in Lung Cancer Patients: A Retrospective Analysis from a Single Institution

  2024cites this paper
• Identification of Proteins Using Supramolecular Gold Nanoparticle-Dye Sensor Arrays.

  2023cites this paper
• Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography

  2023cites this paper
• Predictive value of 18F‐FDG PET/CT and serum tumor markers for tumor mutational burden in patients with non‐small cell lung cancer

  2023cites this paper
• The Usefulness of the Ratio of Antigen–Autoantibody Immune Complexes to Their Free Antigens in the Diagnosis of Non-Small Cell Lung Cancer

  2023cites this paper
• Hollow SnO2/CdS QDs/CdCO3 heterostructured nanocubes coupled with hollow PtPd/MnCo-CeO2 nanozyme-mediated synergistic amplification for ultrasensitive PEC immunoanalysis of lung cancer biomarker.

  2023cites this paper
• Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma

  2023cites this paper
• Serum Biomarker Panel for Rapid Early Diagnosis of Lung Cancer.

  2022cites this paper
• Early detection of lung cancer biomarkers through biosensor

  2022cites this paper
• Employing radiography (X‐rays) to localize lesions in human skeletal remains from past populations to allow accurate biopsy, using examples of cancer metastases

  2022cites this paper
• Prognostic significance of a complement factor H autoantibody in early stage NSCLC

  2022cites this paper
• An Immunoproteomic Survey of the Antibody Landscape: Insights and Opportunities Revealed by Serological Repertoire Profiling

  2022cites this paper
• Hydrophilic rhodamine B-loaded / boronic acid-modified graphene oxide nanocomposite as a substitute of enzyme-labeled second antibody for ultrasensitive detection of antibodies.

  2022cites this paper
• Blood protein biomarkers in lung cancer.

  2022cites this paper
• Diagnosing non-small cell lung cancer by exhaled-breath profiling using an electronic nose: a multicentre validation study.

  2022cites this paper
• An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer

  2021cites this paper
• A Review of Technological Progression from Radiomics to Breathomics for Early Detection of Lung Cancer

  2021cites this paper
• New Role of Red Blood Cells in Absorption of DNA Bearing Tumorigenic Mutations from Lung Cancer Tissue

  2021cites this paper
• Can autoantibody tests enhance lung cancer screening?—an evaluation of EarlyCDT®-Lung in context of the German Lung Cancer Screening Intervention Trial (LUSI)

  2021influential citation
• Liquid biopsies to distinguish malignant from benign pulmonary nodules

  2021cites this paper
• Clinical value of tumor-associated antigens and autoantibody panel combination detection in the early diagnostic of lung cancer

  2021cites this paper
• Antigen Similarity In Hydatid Cyst Wall And Human Bone Tumours: A Short Report

  2021cites this paper
• A novel WSSV responsive plasma protein from Litopenaeus vannamei contributes to hemocytes anti-apoptosis.

  2020cites this paper
• Exosomal miR‐21/Let‐7a ratio distinguishes non‐small cell lung cancer from benign pulmonary diseases

  2020cites this paper
• Clinical value of seven autoantibodies combined detection in the diagnosis of lung cancer

  2020cites this paper
• The diagnostic efficiency of seven autoantibodies in lung cancer

  2019cites this paper
• A Mini Review of Trends towards Automated and Non-Invasive Techniques for Early Detection of Lung Cancer: From Radiomics through Proteogenomics to Breathomics

  2019cites this paper
• Les nouveaux outils biologiques pour améliorer le dépistage du cancer bronchique

  2019cites this paper
• A promising role of interferon regulatory factor 5 as an early warning biomarker for the development of human non-small cell lung cancer.

  2019cites this paper
• The origin and nature of the complex autoantibody profile in cerebrospinal fluid

  2019cites this paper
• Gene polymorphisms of SFTPB rs7316, rs9752 and PAOX rs1046175 affect the diagnostic value of plasma Pro‐SFTPB and DAS in Chinese Han non–small‐cell lung cancer patients

  2019cites this paper
• Diagnosing the RGS11 Lung Cancer Biomarker: The Integration of Competitive Immunoassay and Isothermal Nucleic Acid Exponential Amplification Reaction.

  2019cites this paper
• Thinking Cancer

  2018cites this paper
• Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer.

  2018cites this paper
• Diagnostic Value of Autoantibodies in Lung Cancer: a Systematic Review and Meta-Analysis

  2018cites this paper
• Increased γ-glutamyl transferase positively contributed to the poor prognosis in lung cancer patients

  2018cites this paper
• Using a panel of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of gastric cancer

  2018cites this paper
• Coptis chinensis inhibits growth and metastasis and induces cell apoptosis in non-small cell lung cancer cells

  2017cites this paper
• Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection.

  2017cites this paper
• BARD1 serum autoantibodies for the detection of lung cancer

  2017cites this paper
• The roles and applications of autoantibodies in progression, diagnosis, treatment and prognosis of human malignant tumours.

  2017cites this paper